Tech Company Financing Transactions
T3D Therapeutics Funding Round
Private investors participated in a $6 million funding round for T3D Therapeutics. The funding round was recorded on 3/13/2018.
Transaction Overview
Company Name
Announced On
3/13/2018
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
68 T.W. Alexander Dr. PO Box 13628
Research Triangle Park, NC 27709
USA
Research Triangle Park, NC 27709
USA
Phone
Website
Email Address
Overview
T3D Therapeutics, Inc. was founded in 2013 with a daunting mission -- to challenge the prevailing thinking over the last two decades in the development of solutions to effectively treat Alzheimer's disease. Our mission is to develop a ground-breaking, disease-modifying, new drug for the treatment of Alzheimer's disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Didsbury
Chief Medical Officer
Warren Strittmatter
Chief Scientific Officer
Stan Chamberlain
Browse more venture capital transactions:
Prev: 3/13/2018: Airspace Systems venture capital transaction
Next: 3/13/2018: Voci Technologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs